Opinion: Antibiotic-resistant superbugs are a ticking time bomb in global health care
The global health-care system faces a ticking time bomb. Deadly bacteria and fungi are evolving to resist all current antimicrobials. If that happens, ...
The global health-care system faces a ticking time bomb. Deadly bacteria and fungi are evolving to resist all current antimicrobials. If that happens, ...
Greater investment is needed in antibiotic R&D, and more must be done to maximize the impact of such investments. More widespread data sharing, ...
In 1928, Alexander Fleming discovered penicillin, which would become the first commercialized antibiotic. Ever since, germs have...
West Coast, USA-based Forge Therapeutics has inked a deal with Switzerland's Basilea Pharmaceutica to...
San Diego’s Forge Therapeutics has partnered with Basilea Pharmaceutica to develop antibiotics for the Swiss drug company. The deal gives Forge the opportunity ...
Forge Therapeutics, founded in 2015 with the goal of developing drugs that target metalloenzymes, said Wednesday it had agreed to let Basilea Pharmaceutica ...
As strains of bacteria evolve to fight back against common antibiotics, a slew of biotechnology companies are working to develop ways to combat ...
San Diego's Forge Therapeutics will get information from another company’s unsuccessful effort to develop antibiotics, under a new government-sponsored initiative to help others ...
More than 65,000 Americans have been victims of influenza A H3N2 this season, according the Centers for Disease Control. And this particular strain ...
From about 1,000 square feet in a business incubator, antibiotic developer Forge Therapeutics has moved to a 7,000 square-foot headquarters. The tiny La Jolla ...